E. V. Gerfanova

E. V. Gerfanova

Auto-generated profile, based on publicly available information

E. V. Gerfanova

Academician Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of the Russian Federation

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 April 2015 in Tumors of female reproductive system
Verified
Journal Article
Open access
PDF file
LAL. A. Ashrafyan
L. A. Ashrafyan
NBN. A. Babaeva
N. A. Babaeva
IAI. B. Antonova
I. B. Antonova
SIS. V. Ivashina
S. V. Ivashina
ALA. V. Lyustik
A. V. Lyustik
AДArray А. Добренко
Array А. Добренко
Introduction. Ovarian cancer (OC) in Russia is ranked the seventh within the structure of general cancer diseases and the third within the gynecological tumors, due to such reasons the problem of early diagnostics is still actual. New technologies, such as color Doppler ultrasonography,3D power Doppler ultrasonography contribute to increasing of opportunities of ultrasound analysis to detect any malignancy signs.Materials and methods. The paper sets out the results of comprehensive ultrasound study of 68 patients with morphologically verified OC at stages IА–В, IIА–В. The control group was made of 100 female patients with morphologically verified ovarian tumors (serosal cystadenomas, thecomas, fibromas). A complex of the following ultrasound methods was used during the study: 2D and 3D ultrasonography in B mode, in color Doppler and power mapping mode, 3D angiography, spectrum Doppler imaging.Results. Maximum size of tumor varied within a range between 37 and 300 mm (108 ± 61.2 mm). It worth noting that no direct dependence between the size of neoplasm and process phase was established. When assessing the echostructure, all ovarian tumors were divided into 3 structure types: cystic type (57.8 % of cases), cystic and solid type (33.3 % of cases), solid type (8.9 % of cases). The conducted analysis of types of small pelvis neoplasm echostructures enabled to evolve the sonographic types of ovarian tumors, more or less associated with the malignant transformation. The most relevanl Doppler ultrasonography exponents characteristic for benignant and malignant processes: resistance index in benignant tumors was 0.56, at OC – 0.32 (р 0.001); average arterial blood velocity in benignant tumors – 7.8 cm/s, at OC – 20.1 cm/s (р 0.001); average maximum venous flow velocity in benignant tumors – 3.2 cm/s, at OC – 9.3 cm/s (р 0.001).Conclusion. Therefore modern ultrasonography can detect and differentiate rather efficiently the localized variants of OC, provided that the main part of diagnosis is formed in mode of color and power Doppler mapping, which shall be taken into consideration during the primary diagnostics of OC.

14 August 2023 in Sechenov Medical Journal
Verified
Journal Article
Open access
PDF file
OAO. I. Aleshikova
O. I. Aleshikova
NBN. A. Babaeva
N. A. Babaeva
EGE. V. Gerfanova
E. V. Gerfanova
IAI. B. Antonova
I. B. Antonova
VSVictoria O. Shender
Victoria O. Shender
LAL. A. Ashrafyan
L. A. Ashrafyan
Ovarian cancer (OC) is a heterogenous disease in terms of genetic mutations and tumor phenotypes and can be divided into I and II types. Type II high grade tumors are more common, accompanied by ascites, and are the main cause of cancer-related death in women. OC associated ascites is considered as valuable source of tumor material containing a wide range of dissolved components and cell populations. Over the past decades, the cellular and acellular components of ascites have been studied, but its effect on chemoresistance and the development of metastasis continues to be studied. This review describes the pathogenesis of ascites in OC, it’s cellular and acellular components, many of which are prognostic factors as well as markers of the effectiveness of anticancer therapy. Further study of the ascitic fluid composition in OC will help to identify not only prognostic factors, but also the points of application of targeted drugs and will improve the results of OC treatment.

12 March 2026 in Obstetrics, Gynecology and Reproduction
Verified
Journal Article
Open access
PDF file
VSV. Yu. Shchukin
V. Yu. Shchukin
EGE. V. Gerfanova
E. V. Gerfanova
NBN. A. Babaeva
N. A. Babaeva
OAO. I. Aleshikova
O. I. Aleshikova
NMN. A. Mukhsinzoda
N. A. Mukhsinzoda
LAL. A. Ashrafyan
L. A. Ashrafyan
Human papillomavirus (HPV) is the main risk factor for developing cervical cancer (CC). About 70–75 % of all invasive CC cases worldwide are associated with HPV 16 and 18 genotypes, 20–25 % cases being related to HPV 31, 33, 35, 45, 52, and 58 genotypes. Currently, there are more than 100 tests for HPV diagnostics, but up to now, it has been difficult to establish and evaluate sensitivity of cytological examination for detecting pre-invasive and invasive cervical squamous and glandular lesions. The use of biomarkers for a more objective diagnostics of squamous intraepithelial lesions (SIL) was investigated in numerous studies. The most widely used biomarker is the p16INK4a (p16) antibody that flags E7-induced high-risk HPV-caused cell proliferation. The diagnosis of SIL upon cervical biopsy is also highly variable convincingly supported by the documented evidence. The intermediate category, cervical intraepithelial neoplasia grade 2 (CIN2), provides the least reproducible results. The use of immunohistochemistry p16, alone or in combination with the proliferation marker Ki-67, increases the effectiveness of differentiation between SIL and its benign imitators. Thus, a high degree of variability still is observed between the data of cervical cytology and biopsy due to both sampling errors and the expertise of medical works involved in data interpretation. Atypical squamous cells of undetermined significance (ASC-US) represent the primary source of such variability.

9 September 2025 in Research and Practical Medicine Journal
Verified
Journal Article
Open access
PDF file
ARA. N. Riger
A. N. Riger
BKB. I. Kerimova
B. I. Kerimova
TMT. A. Maryanova
T. A. Maryanova
EGE. V. Gerfanova
E. V. Gerfanova
IAI. B. Antonova
I. B. Antonova
AKAndrei Kaprin
Andrei Kaprin
Возможности применения допплерографии при плоскоклеточной интраэпителиальной неоплазии шейки матки